Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources
←Back to briefings
The Colonial Motor Company (CMO) / HY24

PBT fell 33.5% on a 1.2% revenue dip as inventory ballooned 36.8%

Demand deferral and inventory carrying costs in a high-rate environment compressed margins while total assets swelled to NZ$625.5m.

Consumer / Automotive retail

CMO revenue trajectory

Revenue context before the current result.

↗
Loading chart...
FY23 was $997.2m, versus $1b in FY22.

CMO Operating profit margin

Operating profit margin across covered periods.

↗
Loading chart...
Operating profit margin across covered periods.

CMO operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
FY23 was -$10.2m, versus $67.3m in FY22.

CMO working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • FY22 CMO: Outside range low operating working-capital movement. $-26.4m; 4-period range $-7.9m to $69m. Operating working-capital movement: NZ$-26.4m, below normal range; 2/4 prior periods had builds averaging NZ$56.6m, and 1 had releases averaging NZ$-7.9m.
  • FY23 CMO: Unprecedented high operating working-capital movement. $69m; 4-period range $-26.4m to $44.1m. Operating working-capital movement: NZ$69.0m, unprecedented high; 1/4 prior periods had builds averaging NZ$44.1m, and 2 had releases averaging NZ$-17.1m.
  • HY24 CMO: Unprecedented high operating working-capital movement. $72.6m; 4-period range $-29.6m to $39.7m. Operating working-capital movement: NZ$72.6m, unprecedented high; 2/4 prior periods had builds averaging NZ$33.8m, and 2 had releases averaging NZ$-24.2m.
Operating working-capital movement: NZ$72.6m, unprecedented high; 2/4 prior periods had builds averaging NZ$33.8m, and 2 had releases averaging NZ$-24.2m.

Market context

Valuation

A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.

Prices as at close, 8 June 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$220m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

9.96x

i

Recent market cap compared with trailing earnings.

EPS

0.68

i

Recent filing-derived earnings per share.

PEG

0.18x

i

P/E compared with recent earnings growth.

EV/EBITDA

Not available

i

Not available for this company right now.

P/FCF

Not available

i

Not available for this company right now.

P/B

0.69x

i

Market value compared with latest reported equity.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

5.2%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Release date
21 February 2024
Published
23 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources

Key metrics

Numbers worth scanning first

HY24 vs HY23

Revenue

$494.9m

-1.2% ↓ vs $500.9m

Net profit after tax

$9.3m

-35.0% ↓ vs $14.3m

Net cash inflow from operating activities

−$48.4m

+4.5% ↑ vs −$50.7m

Interim dividend per share

15.0c

flat vs 15.0c

Profit before tax

$13.9m

-33.5% ↓ vs $20.9m

Cash and cash equivalents

$12.8m

-20.8% ↓ vs $16.1m

Total assets

$625.5m

+18.7% ↑ vs $527.1m

What changed

Revenue slipped just 1.2% to NZ$494.9m, but profit before tax fell 33.5% to NZ$13.9m and NPAT fell 35.0% to NZ$9.3m — a sharp negative operating leverage event off a small top-line move

Inventory rose NZ$72.6m (36.8%) to NZ$269.9m, lifting total assets to NZ$625.5m, which is above Annolyse's historical baseline range for the company (4-period mean NZ$539.1m). Cash on hand fell to NZ$12.8m from NZ$16.1m. The interim dividend was held flat at 15.0 cps despite the earnings drop, taking the payout ratio against NPAT to 53.0% from 34.3%.

The release attributes the squeeze to vehicle sales deferred to post-1 January 2024 and the cost of holding inventory for an extended period in a high-interest-rate environment.

What matters

Margin compression on a small revenue move

  1. PBT margin of 2.8% sits within the company's historical range (4-period mean 3.5%), so this is not a structurally broken margin; it is operating deleverage from inventory-financing costs and softer realised volumes. Both growth metrics — PBT –33.5% and NPAT –35.0% — fall below the historical baseline range. This matters because the result is recoverable only if demand returns and inventory clears at acceptable margin.

  2. A NZ$72.6m inventory build and an above-baseline asset base. Operating working capital climbed to NZ$269.9m and total assets are NZ$86.4m above the 4-period mean. With H1 OCF still –NZ$48.4m (vs –NZ$50.7m prior), the business is funding a larger inventory pile in a costlier money environment. This matters because every additional month of stock holding compounds the very cost the result already flagged.

  3. Dividend held at a stretched payout. Holding 15.0 cps interim against a 35% NPAT decline pushes the NPAT payout ratio to 53.0%, the upper edge of the historical range (mean 44.5%). This matters because it leaves less internal funding for inventory and signals board confidence in H2 recovery rather than operating headroom today.

Expectations

No quantitative FY24 target is provided

H1 historically runs at 49.9% of full-year revenue and 43.1% of NPAT (FY23 shape), so the business is structurally H2-weighted; annualising current H1 revenue gives NZ$989.7m versus FY23's NZ$1b. Management commentary points to robust heavy-truck sales into H2 and indicates the demand softening became evident only from November.

The release does not support an inference that the deferred volumes have yet converted, and it does not say margin pressure has eased. The gap between H1 weakness and the implied H2 catch-up needed to match prior years is the central uncertainty in this print.

Quality of result

The earnings fall is operating, not accounting

The current and prior effective tax rates are near identical (28.3% vs 28.1%), so PBT and NPAT growth move together (–33.5% vs –35.0%, a 1.5pp gap) and there is no tax distortion to strip out. There is no discontinued operation or one-off item disclosed. Margins remain within Annolyse's historical baseline range, which is consistent with a timing-and-demand event rather than structural impairment.

Cash quality, however, is weaker than the income statement implies. Operating cash flow improved only marginally and remains deeply negative because the NZ$72.6m inventory build absorbed cash. The slightly better OCF print reflects timing of payables and other working capital, not better trading. Until inventory unwinds, reported earnings overstate cash-generative quality, and the interim dividend is being funded against an above-baseline asset base rather than out of in-period cash. Cash on hand at NZ$12.8m is the lowest comparable point in the supplied range.

Unresolved

Open questions

What proportion of the deferred H1 vehicle sales has actually converted in January and February, and at what realised margin?
Why was inventory allowed to grow NZ$72.6m when softer demand was already evident from November?
What is the current gross-borrowings position and floorplan finance balance given inventory rose 36.8%?
Is the 15.0 cps interim sustainable into the final dividend if H2 demand recovery is slower than the historical second-half-weighting implies?
How does management view H2 gross-margin recovery against still-elevated inventory carrying costs?

This briefing cannot assess segment-level result drivers beyond the dominant operating segment, the current debt and floorplan-finance position, or post-balance-date vehicle sales trajectory in early 2024.

Chat

Ask about CMO HY24

Ask follow-up questions about The Colonial Motor Company's HY24 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about CMO HY24

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about The Colonial Motor Company's HY24 result.

What proportion of the deferred H1 vehicle sales has actually converted in January and February, and at what realised margin?Why does "Margin compression on a small revenue move" matter?How strong was the cash and earnings quality in HY24?What should I watch next for CMO after HY24?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

CMO Half Year Result - six months to 31 December 2023

HY24 / financial report↗

CMO Results Announcement

HY24 / results announcement↗

CMO Results Announcement

HY24 / results release↗

Prior comparable period

CMO Half Year Result - six months to 31 December 2022

HY23 / financial report↗

CMO Results announcement 31 December 2022

HY23 / results announcement↗

CMO Results announcement 31 December 2022

HY23 / results release↗

Full-year context

Preliminary result report CMO 30 June 2022

FY23 / financial report↗

Results announcement

FY23 / results announcement↗

Results announcement

FY23 / results release↗

Release context

2023 annual meeting resolution results

HY24 / commentary↗

Guidance Update

HY24 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 1.5pp, with a distortion flag in the result.

→

Dividend coverage and payout pressure

Dividend payout versus NPAT is 53.0%.

→

Revenue growth context

Revenue growth was -1.2% for this reporting period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when CMO publishes next

Get the next The Colonial Motor Company briefing and related NZX reporting-season updates by email.